← Back to Patent Explorer
US5693067A Expired / Lapsed US ⏱️ 0.0 years remaining

Intravascular device

Assignee: The University of Texas System
•
Filing: 1996-06-12
•
Granted: 1997-12-02
•
Expires: 2016-06-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A multi-element occlusion device (10, 20, 30, 40) provides an improvement over existing systems by increasing the occupation of a vascular lumen. The device (10, 20, 30) comprises an anchoring element (12, 22, 32), a lead element (14, 24, 34) and at least one fiber (16, 26, 36) attaching said elements. The elements and fibers produce a cumulative occlusive effect greater than the sum of the individual elements. When placed in the blood stream, the anchoring element (12, 22, 32) lodges against the vessel wall and the lead element (14, 24, 34) is carried to a position distal thereto. In another embodiment, an"umbrella" of support members extend from the lead element. A fabric web extends between these support members. The umbrella intravascular device expands upon its exit from the catheter. The fabric web produces complete occlusion of the vessel without the need for thrombosis to form between the elements. With the use of multi-element deployment, the device decreases the risk of continued canalization and recanalization.

Inventors

  • 👤 Phillip D. Purdy

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 17:29
CPC Classifications
A; A61; A61B; A61B17/00; A61B17/12; A61B17/12022; A61B17/12099; A61B17/12109; A61B17/12113; A61B17/12131; A61B17/12168; A61B17/12172

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 45 words
An intravascular device comprising: (a) at least one anchoring element; and (b) at least one lead element attached to said at least one anchoring element by a means for attaching, wherein said at least one lead element is a pharmacologic or other biologically active element.
Claim 2
Dependent Claim 45 words
An intravascular device comprising: (a) at least one anchoring element; and (b) at least one lead element attached to said at least one anchoring element by a means for attaching, wherein said at least one lead element is a pharmacologic or other biologically active element.
Claim 3
Dependent Claim 14 words
The intravascular device of claim 1 wherein the pharmacologic agent is a soluble drug.
Claim 4
Dependent Claim 15 words
The intravascular device of claim 1 wherein said pharmacologic object is a clot dissolving drug.
Claim 5
Dependent Claim 21 words
The intravascular device of claim 1 wherein said biologically active agent releases viral particles or other agents used for genetic alteration.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2000-12-01 2001-06-02 2001-12-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2004-12-01 2005-06-02 2005-12-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2008-12-01 2009-06-02 2009-12-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag